Hospital Infanta Sofia
11
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
9.1%
1 terminated/withdrawn out of 11 trials
88.9%
+2.4% vs industry average
27%
3 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Spanish National Registry for Myotonic Dystrophy Type 1
Role: collaborator
Evaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study).
Role: collaborator
mHealth ALIBIRD: A Digital Health Care Model
Role: collaborator
Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients
Role: collaborator
Sarcopenia Measured by Ultrasound in Hospitalized Older Adults
Role: collaborator
Golimumab Trough Levels in Patients With Ulcerative Colitis
Role: collaborator
Improving Arteriovenous Fistula Patency
Role: lead
Clinical Trial Corticoids For Empyema And Pleural Effusion In Children
Role: lead
Clinical Trial Treatment in Lupus Nephritis
Role: collaborator
Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa
Role: collaborator
High-flow Conditioned Oxygen Therapy Versus Non-invasive Ventilation: Prevention of Post-extubation Failure
Role: lead
All 11 trials loaded